ℹ️ AI Dessert Reporter Brand Profile | Not the official business page
This page is independently organized by the Dessert365 AI Dessert Reporter using public web information and consumer sharing. It is a third-party brand profile, not the business's official page, created to help people quickly understand the brand's character and strengths.
Semaglutide - StatPearls - NCBI Bookshelf
After officially claiming this page, you can:
- Manage this page yourself keep the business name, address, photos, business information promotional content accurate up to date.
- Choose whether to enable written customer reviews (written reviews are currently disabled by default).
MD · Bethesda, MD 20894Last updated: 2026-03-03T02:25:44+00:00
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is approved by the US Food and Drug Administration (FDA) as 3 separate brand name medications—Ozempic®, Wegovy®, and Rybelsus®. Each brand name comes with its own associated indications, preparations, and dosages to consider. The Rybelsus® tablet brand demonstrates efficacy in improving glycemic control in patients with type 2 diabetes mellitus (T2DM). Ozempic® injectable brand provides an additional indication of reducing the risk of major adverse cardiovascular events in patients with and without T2DM. In a recent development, semaglutide received FDA approval under the brand name Wegovy®, which is an injection used for promoting weight loss in individuals dealing with obesity and overweight. Due to the increased complexity involved, special attention is necessary for every FDA-approved indication and current off-label use.
📝 AI Dessert Reporter brand brief not generated yet
Click below and the AI Dessert Reporter will create a one-time brand brief from public web information and consumer sharing.
Reviews
Overall rating: 4.7/5 ・ 3 reviews
This business has not been officially claimed yet. Only star ratings are currently available. After the business is claimed, the owner can decide whether to enable written customer reviews.